{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T17:34:49Z","timestamp":1762104889772,"version":"build-2065373602"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T00:00:00Z","timestamp":1715299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T00:00:00Z","timestamp":1715299200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Prescription drug monitoring programs (PDMPs) are state-level databases that track and inform prescribing practices to reduce prescription drug diversion and misuse. To our knowledge, only three studies have examined the impact of PDMPs on opioid-related outcomes among adolescents, and none have focused on prescription pain medication misuse among adolescents.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study leveraged data from the 2019 National Youth Risk Behavior Survey (YRBS) to explore the associations between five categories of PDMP dimensions and the prevalence of self-reported prescription pain medication misuse. Demographic factors\u2019 associations with self-reported prescription pain medication misuse were also examined.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In 2019, none of the PDMP dimensions were associated with self-reported prescription pain medication misuse among U.S. high school students, adjusting for gender, grade, race\/ethnicity, and sexual orientation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>None of the five PDMP dimensions were associated with lower prescription pain medication misuse, however further research is needed, especially as new YRBS data become available.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12889-024-18698-1","type":"journal-article","created":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T05:02:12Z","timestamp":1715317332000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prescription drug monitoring programs and prescription pain medication misuse among U.S. high school students\u20142019"],"prefix":"10.1186","volume":"24","author":[{"given":"Kevin","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Benedetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Evans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,10]]},"reference":[{"key":"18698_CR1","doi-asserted-by":"publisher","unstructured":"McCabe SE, Boyd CJ, Evans-Polce RJ, McCabe VV, Schulenberg JE, Veliz PT. Pills to powder: a 17-Year transition from prescription opioids to Heroin among US adolescents followed into Adulthood. J Addict Med 2021 May-Jun 01;15(3):241\u20134. https:\/\/doi.org\/10.1097\/ADM.0000000000000741. PMID: 32991383; PMCID: PMC7987892.","DOI":"10.1097\/ADM.0000000000000741"},{"key":"18698_CR2","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.amepre.2019.05.017","volume":"57","author":"HB Clayton","year":"2019","unstructured":"Clayton HB, Bohm MK, Lowry R, Ashley C, Ethier KA. Prescription opioid misuse associated with risk behaviors among adolescents. Am J Prev Med. 2019;57:533\u20139.","journal-title":"Am J Prev Med"},{"key":"18698_CR3","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.jpeds.2015.04.071","volume":"167","author":"M Cerda","year":"2015","unstructured":"Cerda M, Santaella J, Marshall BD, Kim JH, Martins SS. Nonmedical prescription opioid use in childhood and early adolescence predicts transitions to heroin use in young adulthood: a national study. J Pediatr. 2015;167:605\u2013e121.","journal-title":"J Pediatr"},{"key":"18698_CR4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.drugalcdep.2017.03.011","volume":"176","author":"CM Jones","year":"2017","unstructured":"Jones CM, Christensen A, Gladden RM. Increases in prescription opioid injection abuse among treatment admissions in the United States, 2004\u20132013. Drug Alcohol Depend. 2017;176:89\u201395.","journal-title":"Drug Alcohol Depend"},{"issue":"11","key":"18698_CR5","doi-asserted-by":"publisher","first-page":"783","DOI":"10.7326\/M17-3074","volume":"168","author":"DS Fink","year":"2018","unstructured":"Fink DS, Schleimer JP, Sarvet A, et al. Association between Prescription Drug Monitoring Programs and Nonfatal and Fatal Drug overdoses: a systematic review. Ann Intern Med. 2018;168(11):783\u201390.","journal-title":"Ann Intern Med"},{"issue":"1","key":"18698_CR6","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1186\/s12913-017-2354-5","volume":"17","author":"EP Finley","year":"2017","unstructured":"Finley EP, Garcia A, Rosen K, et al. Evaluating the impact of prescription drug monitoring program implementation: a scoping review. BMC Health Serv Res. 2017;17(1):420.","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"18698_CR7","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/EDE.0000000000001123","volume":"31","author":"M Cerd\u00e1","year":"2020","unstructured":"Cerd\u00e1 M, Ponicki WR, Smith N, et al. Measuring relationships between proactive reporting state-level prescription drug Monitoring Programs and County-level fatal prescription opioid overdoses. Epidemiology. 2020;31(1):32\u201342.","journal-title":"Epidemiology"},{"key":"18698_CR8","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.addbeh.2017.01.011","volume":"69","author":"M Ali","year":"2017","unstructured":"Ali M, Dowd W, Classen T, Mutter R, Novak S. Prescription drug monitoring programs, nonmedical use of prescription drugs, and heroin use: evidence from the National Survey of Drug Use and Health. Addict Behav. 2017;69:65\u201377.","journal-title":"Addict Behav"},{"key":"18698_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1371\/journal.pmed.1002922","volume":"16","author":"JD Hudgins","year":"2019","unstructured":"Hudgins JD, Porter JJ, Monuteaux MC, Bourgeois FT. Prescription opioid use and misuse among adolescents and young adults in the United States: a national survey study. PLoS Med. 2019;16:11.","journal-title":"PLoS Med"},{"issue":"9","key":"18698_CR10","doi-asserted-by":"publisher","first-page":"e1003272","DOI":"10.1371\/journal.pmed.1003272","volume":"17","author":"JJ Earlywine","year":"2020","unstructured":"Earlywine JJ, Hadland SE, Raifman J. State-level prescription drug monitoring program mandates and adolescent injection drug use in the United States, 1995\u20132017: a difference-in-differences analysis. PLoS Med. 2020;17(9):e1003272.","journal-title":"PLoS Med"},{"issue":"10","key":"18698_CR11","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1001\/jamapediatrics.2020.1980","volume":"174","author":"MS Toce","year":"2020","unstructured":"Toce MS, Michelson K, Hudgins J, et al. Association of State-Level opioid-reduction policies with Pediatric Opioid Poisoning. JAMA Pediatr. 2020;174(10):961\u20138.","journal-title":"JAMA Pediatr"},{"issue":"5","key":"18698_CR12","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s00383-020-04846-2","volume":"37","author":"CM Theodorou","year":"2021","unstructured":"Theodorou CM, Jackson JE, Rajasekar G, et al. Impact of prescription drug monitoring program mandate on postoperative opioid prescriptions in children. Pediatr Surg Int. 2021;37(5):659\u201365.","journal-title":"Pediatr Surg Int"},{"issue":"Suppl\u20131","key":"18698_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.su6901a1","volume":"69","author":"JM Underwood","year":"2020","unstructured":"Underwood JM, Brener N, Thornton J, et al. Overview and methods for the Youth Risk Behavior Surveillance System \u2014 United States, 2019. MMWR Suppl. 2020;69(Suppl\u20131):1\u201310.","journal-title":"MMWR Suppl"},{"issue":"Suppl\u20131","key":"18698_CR14","doi-asserted-by":"publisher","first-page":"38","DOI":"10.15585\/mmwr.su6901a5","volume":"69","author":"CM Jones","year":"2020","unstructured":"Jones CM, Clayton HB, Deputy NP, et al. Prescription opioid misuse and use of Alcohol and other substances among High School Students \u2014 Youth Risk Behavior Survey, United States, 2019. MMWR Suppl. 2020;69(Suppl\u20131):38\u201346.","journal-title":"MMWR Suppl"},{"key":"18698_CR15","unstructured":"Prescription Drug Monitoring Program Training and Technical Assistance Center. PDMP Policies and Practices. 2022. Accessed July 2021."},{"issue":"5","key":"18698_CR16","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1093\/aje\/kwaa267","volume":"190","author":"BW Whitcomb","year":"2021","unstructured":"Whitcomb BW, Naimi AI. Defining, quantifying, and interpreting noncollapsibility in epidemiologic studies of measures of Effect. Am J Epidemiol. 2021;190(5):697\u2013700. https:\/\/doi.org\/10.1093\/aje\/kwaa267. PMID: 33305812; PMCID: PMC8530151.","journal-title":"Am J Epidemiol"},{"issue":"5","key":"18698_CR17","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.amepre.2019.05.006","volume":"57","author":"TE Barnett","year":"2019","unstructured":"Barnett TE, Thompson EL, Litt DM, Lewis MA. Correlates of nonmedical prescription opioid use among U.S. adolescents. Am J Prev Med. 2019;57(5):175\u20139.","journal-title":"Am J Prev Med"},{"key":"18698_CR18","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.addbeh.2017.09.021","volume":"77","author":"DH Li","year":"2018","unstructured":"Li DH, Turner BC, Mustanski B, Phillips GL. Sexual orientation disparities in prescription drug misuse among a nationally representative sample of adolescents: prevalence and correlates. Addict Behav. 2018;77:143\u201351.","journal-title":"Addict Behav"},{"key":"18698_CR19","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.drugalcdep.2015.11.005","volume":"158","author":"JJ Palamar","year":"2016","unstructured":"Palamar JJ, Shearston JA, Dawson EW, et al. Nonmedical opioid use and heroin use in a nationally representative sample of us high school seniors. Drug Alcohol Depend. 2016;158:132\u20138.","journal-title":"Drug Alcohol Depend"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-024-18698-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-024-18698-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-024-18698-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T05:02:35Z","timestamp":1715317355000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-024-18698-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,10]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["18698"],"URL":"https:\/\/doi.org\/10.1186\/s12889-024-18698-1","relation":{},"ISSN":["1471-2458"],"issn-type":[{"type":"electronic","value":"1471-2458"}],"subject":[],"published":{"date-parts":[[2024,5,10]]},"assertion":[{"value":"8 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study used de-identified and publicly available YRBS data and was exempt from IRB review at Nationwide Children\u2019s Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1276"}}